Respiratory ventilators market to reach $1.5 billion by 2028

27 April 2018 (Last Updated November 22nd, 2018 11:20)

Driven by ageing populations, an increasing number of intensive care unit (ICU) admissions and expanding demand for respiratory devices in emerging countries, the global respiratory ventilators market will expand to $1.5bn by 2028, at a steady compound annual growth rate (CAGR) of 2.8%.

Respiratory ventilators market to reach $1.5 billion by 2028

Driven by ageing populations, an increasing number of intensive care unit (ICU) admissions and expanding demand for respiratory devices in emerging countries, the global respiratory ventilators market will expand to $1.5bn by 2028, at a steady compound annual growth rate (CAGR) of 2.8%.

Modern respiratory ventilators strive to ensure patient safety and improve ventilation outcomes while providing portable and cost-effective solutions in a variety of clinical settings. Mechanical ventilators dominate the ventilation devices market, due to their effective functionalities and advanced features.

Due to the large installed base in ICUs and increasing numbers of ICU admissions, the market for critical care ventilators leads the ventilators market with steady growth. Meanwhile, today’s transport ventilators with more advanced modes have consistently gained acceptance. The new technologies of ventilators, including closed-loop modes, automated weaning features, and smart alarm systems, continue to improve patient outcomes, ease of use, and efficiency.

Home care ventilation will be more prevalent in future. Home care ventilators are defined as basic mechanical ventilators intended to provide standard modes of ventilation for neonatal, pediatric, and adult patients for extended time periods at home. These systems are typically not designed for advanced ventilatory support or weaning. Improved ICU care has resulted in many patients surviving acute respiratory failure to require prolonged mechanical ventilation during recovery. Also, mechanical ventilation is increasingly used as a therapeutic option for patients with symptomatic chronic hypoventilation, with an increased effort to predict nocturnal hypoventilation to initiate ventilation earlier. Besides, the rising costs of hospital care and the advent of commercially available home care ventilators and accessories have fueled greater demand for home care ventilation. According to GlobalData’s industry Key Opinion Leader, “The market is small initially. As it [home care ventilation] sees success and deliver cost savings for the healthcare system, I believe it will take off.”


For more insight and data, visit the GlobalData Report Store – Verdict Medical Devices is part of GlobalData Plc.